Candel Therapeutics, Inc.
CADL · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $280 | $261 | $179 | $309 |
| - Cash | $87 | $101 | $92 | $103 |
| + Debt | $6 | $8 | $11 | $13 |
| Enterprise Value | $199 | $168 | $98 | $220 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$11 | -$4 | $8 | -$13 |
| % Margin | – | – | – | – |
| Net Income | -$11 | -$5 | $7 | -$14 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.205 | -0.093 | 0.23 | -0.4 |
| % Growth | -120.5% | -140.5% | 157.5% | – |
| Operating Cash Flow | -$10 | -$9 | -$9 | -$6 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$10 | -$9 | -$9 | -$6 |